BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1563213)

  • 21. Tubular resistance to furosemide contributes to the attenuated diuretic response in nephrotic rats.
    Kirchner KA; Voelker JR; Brater DC
    J Am Soc Nephrol; 1992 Jan; 2(7):1201-7. PubMed ID: 1591361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of response to frusemide in normal subjects.
    Branch RA; Roberts CJ; Homeida M; Levine D
    Br J Clin Pharmacol; 1977 Apr; 4(2):121-7. PubMed ID: 861127
    [No Abstract]   [Full Text] [Related]  

  • 23. Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study.
    Verma AK; da Silva JH; Kuhl DR
    Ann Pharmacother; 2004 Apr; 38(4):544-9. PubMed ID: 14982985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of furosemide on water and sodium excretion in apparently normal infants].
    López Uriarte A; Sánchez Burgos J; Santos Atherton D
    Bol Med Hosp Infant Mex; 1976; 33(3):693-8. PubMed ID: 1275971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute diuretic effect of continuous intravenous infusion of an aqueous extract of Coriandrum sativum L. in anesthetized rats.
    Aissaoui A; El-Hilaly J; Israili ZH; Lyoussi B
    J Ethnopharmacol; 2008 Jan; 115(1):89-95. PubMed ID: 17961943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender effect on diuretic response to hydrochlorothiazide and furosemide.
    Franson KL; Kuk JM; Lam NP; Lau AH
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):101-5. PubMed ID: 8705087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous infusion versus intermittent bolus furosemide in ADHF: an updated meta-analysis of randomized control trials.
    Amer M; Adomaityte J; Qayyum R
    J Hosp Med; 2012 Mar; 7(3):270-5. PubMed ID: 22125127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic and fluid responses to furosemide infusion in the ovine fetus.
    Kelly TF; Moore TR; Brace RA
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):260-8. PubMed ID: 8420337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of furosemide in patients with hepatic cirrhosis.
    González G; Arancibia A; Rivas MI; Caro P; Antezana C
    Eur J Clin Pharmacol; 1982; 22(4):315-20. PubMed ID: 7106167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Furosemide and bumetanide: a study of responses in normal English and German subjects.
    Branch RA; Read PR; Levine D; Elst EV; Shelton J; Rupp W; Ramsay LE
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):538-45. PubMed ID: 1277709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
    Ng KT; Yap JLL
    Anaesthesia; 2018 Feb; 73(2):238-247. PubMed ID: 28940440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):52-7. PubMed ID: 6587655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.
    Hammarlund MM; Odlind B; Paalzow LK
    J Pharmacol Exp Ther; 1985 May; 233(2):447-53. PubMed ID: 3999028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineral excretion following furosemide compared with bumetanide therapy in premature infants.
    Shankaran S; Liang KC; Ilagan N; Fleischmann L
    Pediatr Nephrol; 1995 Apr; 9(2):159-62. PubMed ID: 7794709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dosage regimen on natriuretic response to furosemide.
    Wilson TW; Falk KJ; Labelle JL; Nguyen KB
    Clin Pharmacol Ther; 1975 Aug; 18(2):165-9. PubMed ID: 1097152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy.
    Rudy DW; Voelker JR; Greene PK; Esparza FA; Brater DC
    Ann Intern Med; 1991 Sep; 115(5):360-6. PubMed ID: 1863026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of cyclophosphamide-induced antidiuresis by furosemide infusion.
    Green TP; Mirkin BL
    Clin Pharmacol Ther; 1981 May; 29(5):634-42. PubMed ID: 7214794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
    Vargo DL; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
    Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.